• Wondering if Agilent Technologies at around US$114.54 is offering good value right now, or if the market price is already baking in most of the upside.
• The stock has returned 1.4% over the last 7 days, while the 30 day return is a 3.1% decline and the year to date return is a 17.0% decline, leaving the 1 year return close to flat at a 0.4% decline and longer 3 and 5 year returns at 15.1% and 8.3% declines.
• Recent coverage has focused on Agilent Technologies as a key life sciences and diagnostics player, with investors weighing how sector wide trends and company specific developments might affect long term demand. This context helps explain why the share price has been more muted recently, as the market reassesses both growth potential and risk.
• Agilent Technologies currently holds a valuation score of 4 out of 6, which means several checks suggest the stock could be trading below estimated value. Next up is a closer look at how different valuation methods line up on that view, followed by an even more complete way to think about valuation later in the article.

Approach 1: Agilent Technologies Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow model estimates what a business might be worth by projecting its future cash flows and discounting them back to today, using a required rate of return. It focuses on the cash the company could produce for shareholders rather than just current earnings.

For Agilent Technologies, the latest twelve month Free Cash Flow is about $1.01b. Using a 2 Stage Free Cash Flow to Equity approach, analysts and extrapolations project Free Cash Flow reaching around $2.26b in 2035, with interim annual projections between 2026 and 2035 discounted back to today. Simply Wall St uses analyst inputs where available, then extends the trend for the remaining years.

Pulling these discounted cash flows together, the model arrives at an estimated intrinsic value of about $125.14 per share. Compared with the recent share price of around $114.54, this implies an intrinsic discount of roughly 8.5%. This suggests the stock may be close to its estimated value rather than deeply mispriced.

Result: ABOUT RIGHT

Agilent Technologies is fairly valued according to our Discounted Cash Flow (DCF), but this can change at a moment's notice. Track the value in your watchlist or portfolio and be alerted on when to act.

Approach 2: Agilent Technologies Price vs Earnings

For a profitable company like Agilent Technologies, the P/E ratio is a useful way to gauge what you are paying for each dollar of earnings. Higher growth expectations and lower perceived risk usually justify a higher P/E, while slower growth or higher risk tend to point to a lower, more conservative P/E as being fair.

Agilent Technologies currently trades on a P/E of about 25.1x. That sits below the Life Sciences industry average P/E of roughly 32.6x and also below the peer group average of about 29.9x. On the surface, this suggests the market is applying a lower earnings multiple than it does to many other Life Sciences names.

Simply Wall St’s Fair Ratio for Agilent Technologies is around 22.4x. This Fair Ratio is a proprietary estimate of what a “normal” P/E might be for the company, after accounting for factors such as earnings growth, industry, profit margins, market cap and specific risks. Because it adjusts for these company level drivers, it can be a more tailored yardstick than a simple comparison to industry or peer averages.

Comparing the current P/E of 25.1x with the Fair Ratio of 22.4x suggests the shares are pricing in a somewhat richer multiple than this model implies.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your Agilent Technologies Narrative

Earlier it was mentioned that there is an even better way to understand valuation. Narratives on Simply Wall St’s Community page let you turn your view of Agilent Technologies into a clear story that connects assumptions about future revenue, earnings and margins to a financial forecast, then to a Fair Value you can compare with today’s price. This updates automatically as news or earnings arrive. One investor might build a more optimistic Narrative around the higher US$185.00 analyst target, while another anchors on the more cautious US$150.00 view. You can immediately see how each story lines up against the current market price and decide what it means for your own buy or sell timing.

Do you think there's more to the story for Agilent Technologies? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.